ANDA 76863, held by Barr. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76863 (Metformin Hydrochloride), held by Barr, was first approved by FDA on Oct 14, 2004, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 14, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride750MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 9Labeling · Standard review | Approved | None posted |
| Aug 10, 2026 | Supplement 7Labeling · Standard review | Approved | None posted |
| Aug 10, 2026 | Supplement 5Labeling · Standard review | Approved | None posted |
| Oct 14, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters